← Supplements · Milk Thistle · Molecular Hydrogen · Alcohol & Liver Recovery

DHM (Dihydromyricetin — Hovenia / Vine Tea)

FlavonoidAlcoholLiver

The "hangover pill" flavonoid. It protects the liver from alcohol well in rats, but hasn't been properly tested for hangovers in people.

At a glance

Promising, mostly unproven
Strong human evidence Some human evidence Early (animal / cell)

How to take it

  • 300–600 mg with the first drink or at bedtime
  • Poorly absorbed. More isn't obviously better
  • Sources: Hovenia (Japanese raisin tree) or vine tea (Ampelopsis)
details ↓

Watch out

  • It doesn't make drinking safe or let you drive
  • Few human safety data
  • Sold mostly in blends, where the DHM dose is often unclear
details ↓
The Research

Mechanisms, studies and evidence grades for each claim above.

Less drunk, milder hangover

The DHM story starts with a 2012 Journal of Neuroscience paper from UCLA. In rats, DHM (1 mg/kg, injected) counteracted acute alcohol intoxication (loss of righting reflex) and withdrawal signs (anxiety, seizure susceptibility, tolerance), and greatly reduced voluntary drinking. At the cellular level, it blocked alcohol's potentiation of GABAA receptors and the receptor changes (more α4 subunits) that come with chronic exposure. It seems to act at the benzodiazepine site, because the benzodiazepine antagonist flumazenil cancelled its effects.1 (Animal — clean, well-controlled; injected, not oral)

The gap is human data. A 2026 systematic review of DHM for alcohol-related conditions found 22 studies: 8 in-vitro, 17 in animals and just 2 clinical. Neither clinical study tested isolated DHM; both used Hovenia dulcis extracts, and both saw reductions in hangover severity and some inflammatory markers.2 An earlier review of every randomized hangover trial found only very low quality evidence for any agent — Hovenia fruit extract, L-cysteine, clove extract, red ginseng and Korean pear juice among them — with no two studies testing the same thing.3 (Early for DHM itself; very low quality for Hovenia extract)

Put simply: the rat pharmacology is real, but "DHM prevents hangovers" is an extrapolation that hasn't been tested with the product people actually buy. For a hangover remedy with small human RCTs behind it, molecular hydrogen is about level.

↑ back to summary

Protects the liver from alcohol

The same UCLA group showed that in mice fed alcohol chronically, DHM reduced fatty liver, liver triglycerides and injury markers. It activated AMPK (switching the liver toward burning fat), increased expression of alcohol-metabolizing enzymes, and lowered blood alcohol and acetaldehyde. The authors attribute part of this to raised NAD+, the cofactor alcohol breakdown consumes.4 (Animal)

The faster acetaldehyde clearance is the mechanism most relevant to how people feel the next day, since acetaldehyde drives much of the hangover. It hasn't been measured in humans taking DHM. For a liver herb with actual human biopsy data, see Milk Thistle.

↑ back to summary

Better blood sugar and liver markers in fatty liver

The only proper human trials of DHM are metabolic, not alcohol-related:

Both trials were small, short and from the same institution (the Third Military / Army Medical University in Chongqing). (Moderate — two small RCTs; needs replication outside China)

↑ back to summary

How to take it

↑ back to summary

Safety

Cautions: DHM has no reported serious side effects in the small human trials, but long-term safety data are thin. It doesn't lower blood alcohol enough to make driving safe, and feeling less drunk without actually being less drunk is a risk in itself. Because it acts at the GABAA benzodiazepine site, interactions with benzodiazepines or other sedatives are possible in theory. Avoid in pregnancy for lack of data.
↑ back to summary

References

  1. Shen Y, Lindemeyer AK, Gonzalez C, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci. 2012;32(1):390–401. PMID 22219299
  2. Skinner SG, Matcha S, Davies DL. Therapeutic effects of dihydromyricetin on wholly alcohol-attributed conditions: a systematic review. Nutrients. 2026;18(14):2221. PMID 42514290
  3. Roberts E, Smith R, Hotopf M, Drummond C. The efficacy and tolerability of pharmacologically active interventions for alcohol-induced hangover symptomatology: a systematic review of the evidence from randomised placebo-controlled trials. Addiction. 2022;117(8):2157–2167. PMID 34972259
  4. Silva J, Yu X, Moradian R, et al. Dihydromyricetin protects the liver via changes in lipid metabolism and enhanced ethanol metabolism. Alcohol Clin Exp Res. 2020;44(5):1046–1060. PMID 32267550
  5. Chen S, Zhao X, Wan J, et al. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res. 2015;99:74–81. PMID 26032587
  6. Ran L, Wang X, Lang H, et al. Ampelopsis grossedentata supplementation effectively ameliorates the glycemic control in patients with type 2 diabetes mellitus. Eur J Clin Nutr. 2019;73(5):776–782. PMID 30089792

All six references were checked against PubMed in this session. Refs 1, 2 and 4 all come from one research line (Liang at UCLA, then Davies at USC), so most of the Western DHM evidence depends on one group; Silva 2020 declared no conflicts. The bioavailability figure has no numbered citation yet.